Literature DB >> 11287600

Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits.

H Yuan1, S Puckett, D S Lyles.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) is a potent inhibitor in vivo of transcription by all three host RNA polymerases (RNAP). In the case of host RNA polymerase II (RNAPII), the inhibition is due to lack of activity of the TATA-binding protein (TBP), which is a subunit of the basal transcription factor TFIID. Despite the potency of M protein-induced inhibition in vivo, experiments presented here show that M protein cannot directly inactivate TFIID in vitro. Addition of M protein to nuclear extracts from uninfected cells did not inhibit transcription activity, indicating that the inhibition is indirect and is mediated through host factors. The host factors that are known to regulate TBP activity include phosphorylation by host kinases and association with different TBP-associated factor (TAF) subunits. However, TBP in VSV-infected cells was found to be assembled normally with its TAF subunits, as shown by ion exchange high-pressure liquid chromatography and sedimentation velocity analysis. A normal pattern of phosphorylation of TBP in VSV-infected cells was also observed by pH gradient gel electrophoresis. Collectively, these data indicate that M protein inactivates TBP activity in RNAPII-dependent transcription by a novel mechanism, since the known mechanisms for regulating TBP activity cannot account for the inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287600      PMCID: PMC114196          DOI: 10.1128/JVI.75.9.4453-4458.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98.

Authors:  J P Rodrigues; D Sitterlin; A Bachi; X Wu; M Wilm; M Carmo-Fonseca; E Izaurralde
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

3.  Mitotic phosphorylation of the TBP-containing factor SL1 represses ribosomal gene transcription.

Authors:  A Kuhn; A Vente; M Dorée; I Grummt
Journal:  J Mol Biol       Date:  1998-11-20       Impact factor: 5.469

4.  Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

Authors:  M Ahmed; D S Lyles
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes.

Authors:  J M Petersen; L S Her; V Varvel; E Lund; J E Dahlberg
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Phosphorylation of human general transcription factors TATA-binding protein and transcription factor IIB by DNA-dependent protein kinase--synergistic stimulation of RNA polymerase II basal transcription in vitro.

Authors:  T Chibazakura; F Watanabe; S Kitajima; K Tsukada; Y Yasukochi; H Teraoka
Journal:  Eur J Biochem       Date:  1997-08-01

7.  Casein kinase II regulation of yeast TFIIIB is mediated by the TATA-binding protein.

Authors:  A Ghavidel; M C Schultz
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

8.  Phosphorylation of yeast TBP by protein kinase CK2 reduces its specific binding to DNA.

Authors:  E Maldonado; J E Allende
Journal:  FEBS Lett       Date:  1999-01-29       Impact factor: 4.124

9.  Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.

Authors:  H Yuan; B K Yoza; D S Lyles
Journal:  Virology       Date:  1998-11-25       Impact factor: 3.616

10.  Mitotic silencing of human rRNA synthesis: inactivation of the promoter selectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation.

Authors:  J Heix; A Vente; R Voit; A Budde; T M Michaelidis; I Grummt
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more
  24 in total

1.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  The role of the influenza virus RNA polymerase in host shut-off.

Authors:  Frank T Vreede; Ervin Fodor
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

3.  Inhibition of transcription and translation in Sindbis virus-infected cells.

Authors:  Rodion Gorchakov; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.

Authors:  Natalia Garmashova; Rodion Gorchakov; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Vesicular stomatitis virus as a treatment for colorectal cancer.

Authors:  J H Stewart; M Ahmed; S A Northrup; M Willingham; D S Lyles
Journal:  Cancer Gene Ther       Date:  2011-09-02       Impact factor: 5.987

Review 6.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

7.  Monoclonal antibody against M protein of spring viremia of carp virus.

Authors:  Zeming Li; Qi Zhang; Peixiao Luo; Guangxin Liu; Min Wang; Xueqin Liu
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

8.  Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.

Authors:  John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB.

Authors:  Carola Vogt; Ellen Preuss; Daniel Mayer; Friedemann Weber; Martin Schwemmle; Georg Kochs
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.